4-[(6-Methoxybenzothiazol-2-yl)azo]-N,N-dimethylaniline is an amyloid-binding dye-like ligand structurally related to benzothiazole-based aggregate recognition probes. It is best considered a protein-aggregate recognition scaffold rather than a conventional PROTAC warhead. Its planar aromatic architecture may support binding to ordered amyloid assemblies, making it useful for studying aggregate detection, fibrillar protein recognition, and probe development. In targeted degradation research, this type of ligand would require careful validation because degradation of insoluble or aggregated protein assemblies is mechanistically distinct from standard ubiquitin-proteasome-mediated depletion of soluble proteins. A degrader-like strategy would need to preserve aggregate recognition while recruiting a relevant protein homeostasis pathway. This compound is useful for amyloid chemical biology, fluorescent probe design, protein aggregation studies, and exploratory recognition-based protein homeostasis research.
Structure of 3771-31-1
* For research and manufacturing use only. Not for human or clinical use.
| Size | Price | Stock | Quantity |
|---|---|---|---|
| -- | $-- | In stock |
Looking for different specifications? Click to request a custom quote!
Capabilities & Facilities
Popular Publications Citing BOC Sciences Products
Mechanism of Action: This benzothiazole azo scaffold may support customers developing protein-binding, localization, or degradation-enabling probes. Its aromatic structure can favor interaction with hydrophobic protein environments, making it useful for exploratory studies on protein recognition, reporter design, or scaffold optimization for degradation workflows.
Applications• PROTAC Ligand for E3 Recruitment: 4-[(6-Methoxybenzothiazol-2-yl)azo]-N,N-dimethylaniline can be used as a binding module to engage a chosen target protein in PROTAC architectures. By linking this ligand to an E3 ligase-recruiting moiety, researchers can test whether ternary complex formation promotes ubiquitination and subsequent target degradation.
• Ternary Complex Optimization Studies: Incorporating this ligand into PROTAC constructs enables systematic evaluation of linker length, attachment geometry, and overall physicochemical properties to maximize productive ternary complex formation. These studies can identify degradation-selective conditions by comparing target ubiquitination kinetics and degradation potency across engineered PROTAC variants.
• Target-Selective Degradation Profiling: This ligand can support PROTAC-driven mapping of target dependence by pairing it with different E3 ligases or by using orthogonal control constructs. Measuring protein loss alongside pathway markers helps determine whether degradation is mechanism-driven and whether off-target effects arise from promiscuous binding.
• Structure–Activity Relationship Mapping: The aromatic, heteroaryl, and azo features make this ligand suitable for SAR-driven PROTAC optimization. Researchers can generate analogs or conjugation-site variants to refine affinity and orientation, then correlate changes in binding with degradation efficacy, potency, and duration in cellular protein degradation assays.
This azo-benzothiazole compound is a conjugated dye-like scaffold with limited direct linker-ready functionality. It should be used in PROTAC-style design only after target-binding relevance and a suitable exit vector are established.
Structure: This compound is an azo-linked benzothiazole anilino dye-like scaffold containing a 6-methoxybenzothiazole ring, an azo bridge, and a dimethylamino aniline ring. The conjugated N=N system and electron-donating dimethylamino/methoxy groups dominate its electronic structure.
Reactivity: The structure contains no obvious free acid, amine, alkyne, halide, or alcohol handle for direct PROTAC coupling. If used as a target-binding or reporter-derived ligand, linker installation would require analog synthesis on the dimethylamino aryl ring, methoxy aryl region, or benzothiazole periphery while preserving the azo chromophore if it is functionally relevant. Pairing with CRBN, VHL, or IAP ligands should use alkyl or PEG linkers only after confirming the scaffold has a validated protein-binding target.
* Our calculator is based on the following equation:
Concentration (start) x Volume (start) = Concentration (final) x Volume (final)
It is commonly abbreviated as: C1V1 = C2V2
Please contact us with any specific requirements and we will get back to you as soon as possible.